Literature DB >> 19345326

Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination.

Kexin Xu1, Hermela Shimelis, Douglas E Linn, Richeng Jiang, Xi Yang, Feng Sun, Zhiyong Guo, Hege Chen, Wei Li, Hegang Chen, Xiangtian Kong, Jonathan Melamed, Shengyun Fang, Zhen Xiao, Timothy D Veenstra, Yun Qiu.   

Abstract

The androgen receptor (AR) plays a critical role in prostate cancer. We have identified a ubiquitin E3 ligase, RNF6, as an AR-associated protein in a proteomic screen. RNF6 induces AR ubiquitination and promotes AR transcriptional activity. Specific knockdown of RNF6 or mutation of RNF6-induced ubiquitination acceptor sites on AR selectively alters expression of a subset of AR target genes and diminishes recruitment of AR and its coactivators to androgen-responsive elements present in the regulatory region of these genes. Furthermore, RNF6 is overexpressed in hormone-refractory human prostate cancer tissues and required for prostate cancer cell growth under androgen-depleted conditions. Our data suggest that RNF6-induced ubiquitination may regulate AR transcriptional activity and specificity through modulating cofactor recruitment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19345326      PMCID: PMC2848969          DOI: 10.1016/j.ccr.2009.02.021

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  54 in total

Review 1.  Ubiquitin: structures, functions, mechanisms.

Authors:  Cecile M Pickart; Michael J Eddins
Journal:  Biochim Biophys Acta       Date:  2004-11-29

Review 2.  Ubiquitylation and cell signaling.

Authors:  Kaisa Haglund; Ivan Dikic
Journal:  EMBO J       Date:  2005-09-08       Impact factor: 11.598

3.  E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation.

Authors:  Laurent Le Cam; Laëtitia K Linares; Conception Paul; Eric Julien; Matthieu Lacroix; Elodie Hatchi; Robinson Triboulet; Guillaume Bossis; Ayelet Shmueli; Manuel S Rodriguez; Olivier Coux; Claude Sardet
Journal:  Cell       Date:  2006-11-17       Impact factor: 41.582

Review 4.  Post-translational modifications of steroid receptors.

Authors:  H Faus; B Haendler
Journal:  Biomed Pharmacother       Date:  2006-08-28       Impact factor: 6.529

5.  The ubiquitin ligase Rnf6 regulates local LIM kinase 1 levels in axonal growth cones.

Authors:  Baris Tursun; Anne Schlüter; Marvin A Peters; Birte Viehweger; Heather P Ostendorff; Juliana Soosairajah; Alexander Drung; Michael Bossenz; Steven A Johnsen; Michaela Schweizer; Ora Bernard; Ingolf Bach
Journal:  Genes Dev       Date:  2005-10-01       Impact factor: 11.361

6.  Regulation of androgen receptor activity by tyrosine phosphorylation.

Authors:  Zhiyong Guo; Bojie Dai; Tianyun Jiang; Kexin Xu; Yingqiu Xie; Oekyung Kim; Issa Nesheiwat; Xiangtian Kong; Jonathan Melamed; Venkatesh D Handratta; Vincent C O Njar; Angela M H Brodie; Li-Rong Yu; Timothy D Veenstra; Hegang Chen; Yun Qiu
Journal:  Cancer Cell       Date:  2006-10       Impact factor: 31.743

7.  Lys6-modified ubiquitin inhibits ubiquitin-dependent protein degradation.

Authors:  Fu Shang; Gejing Deng; Qing Liu; Weimin Guo; Arthur L Haas; Bernat Crosas; Daniel Finley; Allen Taylor
Journal:  J Biol Chem       Date:  2005-03-24       Impact factor: 5.157

8.  Itch/AIP4 mediates Deltex degradation through the formation of K29-linked polyubiquitin chains.

Authors:  Patricia Chastagner; Alain Israël; Christel Brou
Journal:  EMBO Rep       Date:  2006-10-06       Impact factor: 8.807

Review 9.  Androgen receptor action in hormone-dependent and recurrent prostate cancer.

Authors:  Irina U Agoulnik; Nancy L Weigel
Journal:  J Cell Biochem       Date:  2006-10-01       Impact factor: 4.429

10.  Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO.

Authors:  Chee-Kwee Ea; Li Deng; Zong-Ping Xia; Gabriel Pineda; Zhijian J Chen
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

View more
  107 in total

Review 1.  Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development.

Authors:  W-L Yang; X Zhang; H-K Lin
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

2.  MST1 is a multifunctional caspase-independent inhibitor of androgenic signaling.

Authors:  Bekir Cinar; Filiz Kisaayak Collak; Delia Lopez; Seckin Akgul; Nishit K Mukhopadhyay; Murat Kilicarslan; Daniel G Gioeli; Michael R Freeman
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

3.  Regulation of Androgen Receptor by E3 Ubiquitin Ligases: for More or Less.

Authors:  Bo Li; Wenfu Lu; Zhenbang Chen
Journal:  Receptors Clin Investig       Date:  2014

Review 4.  Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer.

Authors:  Shan Wang; Dede N Ekoue; Ganesh V Raj; Ralf Kittler
Journal:  Cancer Lett       Date:  2018-09-11       Impact factor: 8.679

5.  The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin.

Authors:  Shu-Ting Chen; Maiko Okada; Ryuichiro Nakato; Kosuke Izumi; Masashige Bando; Katsuhiko Shirahige
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

6.  Pin1 facilitates the phosphorylation-dependent ubiquitination of SF-1 to regulate gonadotropin beta-subunit gene transcription.

Authors:  Zhuojuan Luo; Andrea Wijeweera; Yingzi Oh; Yih-Cherng Liou; Philippa Melamed
Journal:  Mol Cell Biol       Date:  2009-12-07       Impact factor: 4.272

Review 7.  Rationale for the development of alternative forms of androgen deprivation therapy.

Authors:  Sangeeta Kumari; Dhirodatta Senapati; Hannelore V Heemers
Journal:  Endocr Relat Cancer       Date:  2017-05-31       Impact factor: 5.678

Review 8.  Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy.

Authors:  Jason P Chua; Andrew P Lieberman
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-12       Impact factor: 4.388

9.  Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer.

Authors:  Ilona N Holcomb; Janet M Young; Ilsa M Coleman; Keyan Salari; Douglas I Grove; Li Hsu; Lawrence D True; Martine P Roudier; Colm M Morrissey; Celestia S Higano; Peter S Nelson; Robert L Vessella; Barbara J Trask
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

Review 10.  Adaptation or selection--mechanisms of castration-resistant prostate cancer.

Authors:  Yang Zong; Andrew S Goldstein
Journal:  Nat Rev Urol       Date:  2012-12-18       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.